ITEOS THERAPEUTICS INC (ITOS)
Institutional ownership reported to the SEC as of Q3 2025, across 21 quarters.
1
Reporting holders
$2.4K
Reported value
0.0%
Held as options
-127
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $2.4K | 232 | 0.00% | 4q | +0.9% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | $2.4K | 232 | 0 | 1 | 0 | 0.0% |
| Q2 2025 | 128 | $388.3M | 37,635,101 | 38 | 53 | 27 | 3.6% |
| Q1 2025 | 120 | $221.6M | 36,302,969 | 14 | 36 | 42 | 2.4% |
| Q4 2024 | 127 | $282.2M | 33,586,379 | 17 | 44 | 42 | 8.8% |
| Q3 2024 | 139 | $404.3M | 37,119,836 | 19 | 55 | 43 | 6.9% |
| Q2 2024 | 130 | $574.8M | 36,707,861 | 20 | 46 | 44 | 5.6% |
| Q1 2024 | 122 | $504.7M | 36,959,417 | 16 | 31 | 46 | 0.5% |
| Q4 2023 | 121 | $396.0M | 34,927,867 | 20 | 45 | 32 | 3.8% |
| Q3 2023 | 131 | $387.6M | 34,616,585 | 15 | 50 | 42 | 2.5% |
| Q2 2023 | 126 | $420.6M | 31,573,147 | 16 | 50 | 37 | 0.5% |
| Q1 2023 | 126 | $440.9M | 32,372,149 | 23 | 38 | 44 | 0.3% |
| Q4 2022 | 115 | $643.7M | 33,792,292 | 19 | 38 | 32 | 0.1% |
| Q3 2022 | 137 | $703.5M | 36,917,717 | 16 | 62 | 32 | 0.0% |
| Q2 2022 | 151 | $778.6M | 37,446,059 | 31 | 71 | 30 | 0.9% |
| Q1 2022 | 158 | $1.2B | 36,302,638 | 53 | 48 | 40 | 0.2% |
| Q4 2021 | 116 | $1.6B | 33,499,283 | 41 | 37 | 22 | 0.0% |
| Q3 2021 | 76 | $841.3M | 31,151,512 | 12 | 26 | 24 | 0.0% |
| Q2 2021 | 82 | $761.1M | 29,674,406 | 22 | 28 | 23 | 0.0% |
| Q1 2021 | 78 | $1.0B | 30,086,153 | 16 | 35 | 13 | 0.0% |
| Q4 2020 | 71 | $906.8M | 26,900,668 | 20 | 24 | 12 | 0.0% |
| Q3 2020 | 54 | $614.3M | 24,955,661 | 54 | 0 | 0 | 0.0% |